Analysts expect that Envision Healthcare Corporation (NYSE:EVHC) will report $1.99 billion in sales for the current quarter, according to Zacks Investment Research. Eight analysts have issued estimates for Envision Healthcare Corporation’s earnings, with the highest sales estimate coming in at $2.06 billion and the lowest estimate coming in at $1.94 billion. Envision Healthcare Corporation posted sales of $822.22 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 142%. The firm is expected to announce its next earnings report after the market closes on Tuesday, October 31st.

According to Zacks, analysts expect that Envision Healthcare Corporation will report full year sales of $1.99 billion for the current fiscal year, with estimates ranging from $7.78 billion to $8.01 billion. For the next fiscal year, analysts expect that the business will post sales of $8.73 billion per share, with estimates ranging from $8.28 billion to $9.06 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that that provide coverage for Envision Healthcare Corporation.

Envision Healthcare Corporation (NYSE:EVHC) last released its earnings results on Monday, August 7th. The company reported $0.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.75 by $0.04. Envision Healthcare Corporation had a positive return on equity of 5.35% and a negative net margin of 7.35%. The company had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.96 billion. During the same period in the prior year, the company posted $0.34 earnings per share. Envision Healthcare Corporation’s quarterly revenue was up 156.7% on a year-over-year basis.

A number of equities research analysts have weighed in on the stock. Zacks Investment Research upgraded shares of Envision Healthcare Corporation from a “sell” rating to a “hold” rating in a research note on Friday, August 11th. Mizuho decreased their target price on shares of Envision Healthcare Corporation from $65.00 to $57.00 and set a “neutral” rating for the company in a research note on Wednesday, August 9th. BidaskClub lowered shares of Envision Healthcare Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, August 1st. Cantor Fitzgerald reiterated a “buy” rating and set a $80.00 target price on shares of Envision Healthcare Corporation in a research note on Tuesday, July 4th. Finally, Jefferies Group LLC set a $71.00 target price on shares of Envision Healthcare Corporation and gave the company a “buy” rating in a research note on Thursday, August 24th. Two analysts have rated the stock with a sell rating, one has given a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $73.00.

Envision Healthcare Corporation (EVHC) opened at 43.40 on Monday. Envision Healthcare Corporation has a one year low of $39.66 and a one year high of $74.75. The company’s market capitalization is $5.08 billion. The firm’s 50-day moving average price is $44.58 and its 200 day moving average price is $53.51.

Envision Healthcare Corporation announced that its Board of Directors has initiated a share repurchase plan on Monday, September 18th that allows the company to buyback $250.00 million in shares. This buyback authorization allows the company to reacquire up to 4.5% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s board of directors believes its stock is undervalued.

Several hedge funds have recently modified their holdings of the company. Crossmark Global Holdings Inc. bought a new stake in shares of Envision Healthcare Corporation during the 3rd quarter valued at $502,000. Private Capital Management Inc. grew its position in shares of Envision Healthcare Corporation by 37.2% during the 3rd quarter. Private Capital Management Inc. now owns 10,700 shares of the company’s stock valued at $481,000 after acquiring an additional 2,900 shares during the period. Honeywell International Inc. grew its position in shares of Envision Healthcare Corporation by 17.4% during the 3rd quarter. Honeywell International Inc. now owns 542,100 shares of the company’s stock valued at $24,367,000 after acquiring an additional 80,200 shares during the period. First Bank & Trust grew its position in shares of Envision Healthcare Corporation by 32.6% during the 3rd quarter. First Bank & Trust now owns 7,425 shares of the company’s stock valued at $334,000 after acquiring an additional 1,827 shares during the period. Finally, Reinhart Partners Inc. grew its position in shares of Envision Healthcare Corporation by 60.3% during the 3rd quarter. Reinhart Partners Inc. now owns 625,713 shares of the company’s stock valued at $28,126,000 after acquiring an additional 235,355 shares during the period.

ILLEGAL ACTIVITY NOTICE: This piece was originally reported by American Banking News and is the property of of American Banking News. If you are reading this piece on another publication, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/10/30/zacks-brokerages-expect-envision-healthcare-corporation-evhc-will-announce-quarterly-sales-of-1-99-billion.html.

Envision Healthcare Corporation Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Get a free copy of the Zacks research report on Envision Healthcare Corporation (EVHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.